睑板腺功能障碍临床诊断新进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Recent advances in the clinical examinations of Meibomian gland dysfunction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    睑板腺功能障碍(meibomian gland dysfunction,MGD)是眼科门诊常见的疾病之一,临床上MGD的诊断需根据症状、体征和相应的辅助检查进行综合评估。传统的检查方法如裂隙灯检查、泪膜破裂时间、泪液分泌试验等在MGD的诊断中有着明确的价值,而在2017年我国睑板腺功能障碍诊断与治疗专家共识中,一些新兴的临床检查方法如睑板腺缺失率、泪膜脂质层厚度等也作为MGD的辅助诊断标准。传统的方法和新兴的检测技术结合起来用于MGD的诊断,将会得到更全面、准确的结论。

    Abstract:

    Meibomian gland dysfunction(MGD)is one of the common diseases in ophthalmology clinic. The diagnosis of MGD ought to be evaluated according to symptoms, signs and corresponding assistant examinations. Traditional examination methods, such as slit-lamp examination, break-up time of tear film, Schirmer tear test and so on, have definite value in the diagnosis of MGD. In 2017, the experts on the diagnosis and treatment of Meibomian gland dysfunction in our country have reached consensus that some novel clinical examination methods such as Meibomian gland loss rate and tear film lipid layer thickness are also worked as auxiliary diagnostic criteria for MGD. The combination of traditional methods and new detection techniques will lead to more comprehensive and accurate conclusions for the diagnosis of MGD.

    参考文献
    相似文献
    引证文献
引用本文

陈旭,马华峰.睑板腺功能障碍临床诊断新进展.国际眼科杂志, 2018,18(6):1051-1054.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-12-21
  • 最后修改日期:2018-04-11
  • 录用日期:
  • 在线发布日期: 2018-05-25
  • 出版日期:
文章二维码